Emicizumab-kxwh Subcutaneous and Metformin and pioglitazone
Determining the interaction of Emicizumab-kxwh Subcutaneous and Metformin and pioglitazone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Metformin and repaglinide
- Emicizumab-kxwh Subcutaneous-Metformin and saxagliptin
- Emicizumab-kxwh Subcutaneous-Metformin and sitagliptin
- Emicizumab-kxwh Subcutaneous-Metformin Extended-Release Tablets
- Emicizumab-kxwh Subcutaneous-Metformin Hydrochloride
- Emicizumab-kxwh Subcutaneous-Metformin Oral Solution
- Metformin and pioglitazone-Emla
- Metformin and pioglitazone-Emla Topical
- Metformin and pioglitazone-Emo-Cort Scalp Solution Topical application
- Metformin and pioglitazone-Emo-Cort Topical application
- Metformin and pioglitazone-Emoquette
- Metformin and pioglitazone-Empagliflozin